AIRLINK 150.25 Increased By ▲ 13.66 (10%)
BOP 10.12 Increased By ▲ 1.00 (10.96%)
CNERGY 7.42 Increased By ▲ 1.00 (15.58%)
CPHL 71.13 Increased By ▲ 6.47 (10.01%)
FCCL 45.71 Increased By ▲ 4.16 (10.01%)
FFL 14.34 Increased By ▲ 1.30 (9.97%)
FLYNG 37.15 Increased By ▲ 3.38 (10.01%)
HUBC 138.35 Increased By ▲ 12.58 (10%)
HUMNL 12.40 Increased By ▲ 1.00 (8.77%)
KEL 4.56 Increased By ▲ 0.55 (13.72%)
KOSM 4.99 Increased By ▲ 1.00 (25.06%)
MLCF 69.65 Increased By ▲ 6.33 (10%)
OGDC 203.01 Increased By ▲ 18.46 (10%)
PACE 5.38 Increased By ▲ 0.96 (21.72%)
PAEL 44.24 Increased By ▲ 4.02 (10%)
PIAHCLA 13.45 Increased By ▲ 1.22 (9.98%)
PIBTL 8.62 Increased By ▲ 1.00 (13.12%)
POWER 14.96 Increased By ▲ 1.09 (7.86%)
PPL 152.75 Increased By ▲ 13.89 (10%)
PRL 27.02 Increased By ▲ 2.46 (10.02%)
PTC 19.29 Increased By ▲ 1.75 (9.98%)
SEARL 75.06 Increased By ▲ 6.82 (9.99%)
SSGC 30.46 Increased By ▲ 2.77 (10%)
SYM 13.95 Increased By ▲ 1.27 (10.02%)
TELE 6.93 Increased By ▲ 0.99 (16.67%)
TPLP 8.00 Increased By ▲ 1.00 (14.29%)
TRG 61.90 Increased By ▲ 5.63 (10.01%)
WAVESAPP 8.94 Increased By ▲ 1.00 (12.59%)
WTL 1.31 Increased By ▲ 0.15 (12.93%)
YOUW 3.75 Increased By ▲ 0.54 (16.82%)
AIRLINK 150.25 Increased By ▲ 13.66 (10%)
BOP 10.12 Increased By ▲ 1.00 (10.96%)
CNERGY 7.42 Increased By ▲ 1.00 (15.58%)
CPHL 71.13 Increased By ▲ 6.47 (10.01%)
FCCL 45.71 Increased By ▲ 4.16 (10.01%)
FFL 14.34 Increased By ▲ 1.30 (9.97%)
FLYNG 37.15 Increased By ▲ 3.38 (10.01%)
HUBC 138.35 Increased By ▲ 12.58 (10%)
HUMNL 12.40 Increased By ▲ 1.00 (8.77%)
KEL 4.56 Increased By ▲ 0.55 (13.72%)
KOSM 4.99 Increased By ▲ 1.00 (25.06%)
MLCF 69.65 Increased By ▲ 6.33 (10%)
OGDC 203.01 Increased By ▲ 18.46 (10%)
PACE 5.38 Increased By ▲ 0.96 (21.72%)
PAEL 44.24 Increased By ▲ 4.02 (10%)
PIAHCLA 13.45 Increased By ▲ 1.22 (9.98%)
PIBTL 8.62 Increased By ▲ 1.00 (13.12%)
POWER 14.96 Increased By ▲ 1.09 (7.86%)
PPL 152.75 Increased By ▲ 13.89 (10%)
PRL 27.02 Increased By ▲ 2.46 (10.02%)
PTC 19.29 Increased By ▲ 1.75 (9.98%)
SEARL 75.06 Increased By ▲ 6.82 (9.99%)
SSGC 30.46 Increased By ▲ 2.77 (10%)
SYM 13.95 Increased By ▲ 1.27 (10.02%)
TELE 6.93 Increased By ▲ 0.99 (16.67%)
TPLP 8.00 Increased By ▲ 1.00 (14.29%)
TRG 61.90 Increased By ▲ 5.63 (10.01%)
WAVESAPP 8.94 Increased By ▲ 1.00 (12.59%)
WTL 1.31 Increased By ▲ 0.15 (12.93%)
YOUW 3.75 Increased By ▲ 0.54 (16.82%)
BR100 12,402 Increased By 1161.5 (10.33%)
BR30 35,560 Increased By 3425.8 (10.66%)
KSE100 117,298 Increased By 10123.1 (9.45%)
KSE30 35,839 Increased By 3190.7 (9.77%)

BEIJING: Iron ore futures prices extended their rise to hit the highest level in multiple weeks on Monday, bolstered by an obvious reduction in shipments and hopes that top consumer China will roll out more stimulus to prop up its economy.

The most-traded September iron ore contract on China’s Dalian Commodity Exchange (DCE) ended daytime trade 2.18% higher at 845.5 yuan ($116.80) a metric ton, the highest since Mar. 26.

The benchmark May iron ore on the Singapore Exchange was 1.31% higher at $112.5 a ton, as of 0720 GMT, the highest since Mar. 11. Dalian iron ore rose for a sixth straight trading session, while the Singapore contract rose for a third straight session.

Iron ore shipments from top suppliers Australia and Brazil tumbled by 28.8% week-on-week to 19.19 million tons in the week of Apr.8-14, data from consultancy Mysteel showed.

China’s economy is expected to have slowed in the first quarter as a protracted property downturn and weak private-sector confidence weighed on demand, maintaining pressures on policymakers to unveil more stimulus measures.

Also, new-bank lending in China rose less than expected in March from the previous month, while broad credit growth hit a record low and property woes lingered. State-backed Chinese real estate developer Vanke said it is facing short-term liquidity pressures and operational difficulties but has prepared “a basket of plans” to stabilise its business and cut debt.

Other steelmaking ingredients on the DCE recorded gains, with coking coal and coke up 3.97% and 2.92%, respectively.

Comments

Comments are closed.